MIRA INFORM REPORT

 

 

Report No. :

330706

Report Date :

08.07.2015

 

IDENTIFICATION DETAILS

 

Name :

DIVI’S LABORATORIES LIMITED

 

 

Registered Office :

7-1-77/E/1/303, Dharam Karan Road, Amarpret, Hyderabad-500016, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

12.10.1990

 

 

Com. Reg. No.:

01-011854

 

 

Capital Investment / Paid-up Capital :

Rs.265.500 Million

 

 

CIN No.:

[Company Identification No.]

L24110AP1990PLC011854

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDD00549D

 

 

Legal Form :

A Public Limited Liability Company.  The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

The company is engaged in manufacturing and sale of active pharma ingredients and intermediates.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa (74)

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Maximum Credit Limit :

USD 101800000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Divi’s Laboratories Limited was incorporated in 1990 by Dr. Murli K Divi.

 

It is a well-established and a reputed company having fine track record.

 

Financial position of the company seems to be sound. Fundamentals are strong and healthy.

 

Company has current market value of Rs.1914.65/- which was initially issued at face value of Rs. 2/-.

 

Directors are reported to be an experienced and respectable businessmen.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facilities = AA+

Rating Explanation

High credit quality and low credit risk

Date

07.10.2014

 

 

Rating Agency Name

CARE

Rating

Short Term Bank Facilities = A1+

Rating Explanation

Very strong degree of safety and lowest credit risk

Date

07.10.2014

 

 Note: CARE site not working so couldn’t attached the external rating sheet.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

LOCATIONS

 

Registered Office :

7-1-77/E/1/303, Dharam Karan Road, Amarpret, Hyderabad – 500016, Andhra Pradesh, India

Tel. No.:

91-40-23731318/ 23731760 / 61 / 23786300

Fax No.:

91-40-23733242 / 23786460

E-Mail :

mail@divislaboratories.com

marketing@divislaboratories.com

kiran@divislaboratories.com

chemicals@divislaboratories.com

kishore@divislaboratories.com

purchase@divislaboratories.com

nlr@divislaboratories.com

Website :

http://www.divislabs.com

http://www.divislaboratories.com

 

 

Factory 1 :

Choutuppal Unit

 

Lingojigudem Village, Choutuppal Mandal, Nalgonda – 508252, Andhra Pradesh, India

Tel. No.:

91-8694-272092, 272260

Fax No.:

91-8694-272685

 

 

Factory 2 :

100% Export Oriented Unit – Chippada / Divi’s Pharma SEZ / DSN SEZ Unit

 

Chippada Village, Bheemunipatnam Mandal, Visakhapatnam-531162, Andhra Pradesh, India

Tel. No.:

91-8922-245166

Fax No.:

91-8922-245165

 

 

R and D Centers:

Located At:

 

  • B-34, Industrial Estate, Sanathnagar, Hyderabad - 500 018, Andhra Pradesh, India
  • Lingojigudem Village, Choutuppal Mandal, Nalgonda - 508 252, Andhra Pradesh, India
  • Chippada Village, Bheemunipatnam Mandal, Visakhapatnam-531 162, Andhra Pradesh, India

 

 

DIRECTORS

 

As on 31.03.2014

 

Name :

Dr. Murali K Divi

Designation :

Chairman and Managing Director

Date of Birth / Age :

62 Years

Qualification :

M. Pharm. Ph.D.

 

 

Name :

Mr. N V Ramana

Designation :

Executive Director

Date of Birth / Age :

55 Years

Qualification :

B.Sc. (Chem)

 

 

Name :

Mr. Madhusudana Rao Divi

Designation :

Director (Projects)

Date of Birth / Age :

14.01.1944

Qualification :

Post-graduate degree in Structural Engineering from Mysore University, Karnataka

Date of Appointment :

14.10.1994

 

 

Name :

Mr. Kiran S. Divi

Designation :

President Director

Date of Birth / Age :

37 Years

Qualification :

B. Pharm.

 

 

Name :

Dr. K. Satyanarayana*

Designation :

Director

 

 

Name :

Mr. S. Vasudev*

Designation :

Director

 

 

Name :

Dr. G. Suresh Kumar

Designation :

Director

Date of Birth / Age :

22.01.1951

Qualification :

  • MBBS from Gandhi Medical College, Hyderabad.
  • M.S. (General Surgery) from Gulbarga University, Karnataka.

Date of Appointment :

10.03.2001

 

 

Name :

Mr. R. Ranga Rao**

Designation :

Director

Date of Birth / Age :

10.07.1951

Qualification :

Post-graduate degree in Pharmacy from College of Pharmacy, Manipal, Karnataka.

Date of Appointment :

03.11.2012

 

*Resigned w.e.f. 23.06.2014

Note : Sri. K.V.K. Seshavataram and Smt. S. Sridevi have been appointed as additional directors w.e.f. 23.06.2014.

 

 

KEY EXECUTIVES

 

Name :

Mr. P.V. Lakshmi Rajani

Designation :

Company Secretary

 

 

Name :

Mr. L. Kishore Babu

Designation :

Chief Financial Officer

 

 

SHAREHOLDING PATTERN

 

As on 31.03.2015

 

Category of Shareholder

Total No. of Shares

Total Shareholding as a % of Total No. of Shares

 

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

65080616

49.03

http://www.bseindia.com/include/images/clear.gifBodies Corporate

4000000

3.01

http://www.bseindia.com/include/images/clear.gifSub Total

69080616

52.04

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals (Non-Residents Individuals / Foreign Individuals)

50000

0.04

http://www.bseindia.com/include/images/clear.gifSub Total

50000

0.04

Total shareholding of Promoter and Promoter Group (A)

69130616

52.08

(B) Public Shareholding

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

18314548

13.80

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

794478

0.60

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

25694788

19.36

http://www.bseindia.com/include/images/clear.gifSub Total

44803814

33.75

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

8894430

6.70

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

Individual shareholders holding nominal share capital up to Rs. 0.100 Million

7580517

5.71

Individual shareholders holding nominal share capital in excess of Rs. 0.100 Million

864522

0.65

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

1460391

1.10

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

791290

0.60

http://www.bseindia.com/include/images/clear.gifDirectors & their Relatives & Friends

471539

0.36

http://www.bseindia.com/include/images/clear.gifTrusts

143837

0.11

http://www.bseindia.com/include/images/clear.gifClearing Members

53725

0.04

http://www.bseindia.com/include/images/clear.gifSub Total

18799860

14.16

Total Public shareholding (B)

63603674

47.92

Total (A)+(B)

132734290

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

132734290

0.00

 

 

 


 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in manufacturing and sale of active pharma ingredients and intermediates.

 

 

Products :

Product Description

ITC Code

Naproxen

2907.29.90

Dextromethorphan HBR

2942.00.90

Levetiracetam

2942.00.90

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

PRODUCTION STATUS = NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Not Available

 

 

Customers :

Not Available

 

 

 

No. of Employees :

Not Available

 

 

Bankers :

  • State Bank of Hyderabad
  • State Bank of India
  • The Lakshmi Vilas Bank Limited

·         Bank of Nova Scotia

 

 

Facilities :

SECURED LOANS

 

Particulars

31.03.2015

Rs. In Million

31.03.2014

Rs. In Million

Short Term Borrowings

 

 

Working Capital Loans from banks

NA

163.100

Overdraft against Fixed Deposits from banks

NA

0.137

Total

NA

163.237

 

Short Term Borrowings

 

Working Capital Loans from banks (Secured) :

 

1.     Nature of Security : Secured by hypothecation of stocks, book debts and receivables and further secured by second charge on fixed assets of the company)

2.     There are no defaults in repayment of loans and interest

3.     The above loans carry interest @ 10% to 12.50% p.a.

 

Overdraft against Fixed Deposits from banks (Secured) : 

 

1.     Nature of Security : Secured by hypothecation of Fixed Deposits of the    company

2.     There are no defaults in repayment of loans and interest

3.     The above loans carry interest @ 9.00% to 9.75% p.a.

 

Auditors :

 

Name :

P.V.R.K. Nageswara Rao and Company

Chartered Accountants

Address :

109, Metro Residency, 6-3-1247, Rajbhavan Road, Hyderabad – 500 082, Andhra Pradesh, India

 

 

Cost Auditors :

 

Name :

EVS and Associates

Cost Accountants

Address :

206, Raghava Ratna Towers, Chirag Ali Lane, Hyderabad – 500 001, Andhra Pradesh, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Wholly Owned Subsidiary 

[AS ON 31.03.2014] :

  • Divis Laboratories (USA) Inc., USA
  • Divi’s Laboratories EUROPE AG, Switzerland

 

 

Company In Which Key Management Personnel have Significant Influence

[AS ON 31.03.2014]:

  • Divi’s Biotech Private Limited
  • Divis Pharmaceuticals Private Limited
  • Divi’s Resorts Private Limited
  • Touchstone Equities Limited
  • Divi’s Properties Private Limited

 

 

CAPITAL STRUCTURE

 

Authorised Capital : Not Available

 

Issued Subscribed & Paid-up Capital : Rs.265.500 Million

 

 

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

150000000

Equity Shares

Rs.2/- each

Rs.300.000 Million

 

 

 

 

 

Issued Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

132734290

Equity Shares

Rs.2/- each

Rs.265.469 Million

 

 

 

 

 

Reconciliation of the number of shares

 

Equity Shares

Number of Shares

Shares outstanding at the beginning of the year

132734290

Shares issued during the year

-

Shares outstanding at the end of the year

132734290

 

Details of equity shares held by shareholders holding more than 5% shares:

 

Name of Shareholder

Number of Shares

% holding

Promoters Group :

 

 

Dr.Murali Krishna Prasad Divi

7783500

5.86%

Satchandra Kiran Divi

23000000

17.33%

Swarnalatha Divi

7000000

2.27%

Nilima Motaparti

27000000

20.34%

Other Than Promoters Group :

 

 

Reliance Capital Trustee Company Limited

10073608

7.59%

 

Aggregate number of bonus shares issued during the period of five years immediately preceding the reporting date

 

On 2nd August 2009, the company issued 64847975 equity shares of Rs.2/- each as fully paid bonus shares by capitalization of general reserve and other free reserves.

 

Terms/rights attached to equity shares:

 

The company has only one class of equity shares having a par value of Rs.2/- per share. Each holder of equity shares is entitled to one vote per share. The company declares and pays dividend in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting.

 

During the year ended 31st March 2014, the amount of per share dividend recognized as distribution to equity shareholders was Rs.20/- (31st March 2013 : Rs. 15/-)

 

In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

 

 

LISTING DETAILS:

 

 

Subject Stock Code :

 

BSE : 532488

 

NSE : DIVISLAB

 

 

Stock Exchange Place :

The Stock Exchange, Mumbai, National Stock Exchange of India Limited

 

Listed Date :

 

08.02.1995

 

·        
ISIN :

 

INE361B01024

 

 

 


FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

265.500

265.469

265.469

(b) Reserves & Surplus

35354.100

30078.693

25267.312

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

35619.600

30344.162

25532.781

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

10.500

15.506

21.004

(b) Deferred tax liabilities (Net)

1324.500

1216.717

865.521

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

69.900

31.821

23.909

Total Non-current Liabilities (3)

1404.900

1264.044

910.434

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

250.700

163.237

305.145

(b) Trade payables

2243.800

1486.929

1583.073

(c) Other current liabilities

2027.300

1465.485

1293.535

(d) Short-term provisions

3201.400

3115.776

2334.164

Total Current Liabilities (4)

7723.200

6231.427

5515.917

 

 

 

 

TOTAL

44747.700

37839.633

31959.132

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

15269.00

12216.015

9084.990

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

1444.846

3034.144

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Expenditure during construction period pending capitalization

0.000

0.000

0.000

(c) Non-current Investments

28.200

28.161

28.161

(d) Deferred tax assets (net)

0.000

0.000

1072.705

(e)  Long-term Loan and Advances

1490.700

1190.239

0.000

(f) Other Non-current assets

0.000

 0.000

0.000

Total Non-Current Assets

16787.900

14879.261

13220.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

7330.000

5018.762

4078.136

(b) Inventories

11149.000

8932.705

8059.484

(c) Trade receivables

8230.300

7916.359

5589.006

(d) Cash and cash equivalents

566.600

357.676

346.828

(e) Short-term loans and advances

591.600

673.751

598.911

(f) Other current assets

92.300

61.119

66.767

Total Current Assets

27959.800

22960.372

18739.132

 

 

 

 

TOTAL

44747.700

37839.633

31959.132

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

30840.100

25139.654

21288.899

 

 

Other Income

428.400

839.026

485.125

 

 

TOTAL                                     (A)

31268.500

25978.680

21774.024

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Raw materials consumed

14462.700

10318.944

8978.981

 

 

Purchases of Stock-in-trade

0.000

0.000

0.943

 

 

Changes in inventories of finished goods, work-in progress and Stock-in-trade

(2308.300)

(1137.505)

(1003.310)

 

 

Employee benefits expense

2831.500

2254.266

1912.018

 

 

Research and development expenses

0.000

253.913

239.987

 

 

Other expenses

4233.700

3261.485

2942.835

 

 

TOTAL                                     (B)

19219.600

14951.103

13071.454

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

12048.900

11027.577

8702.570

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

18.600

20.552

17.765

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

12030.300

11007.025

8684.805

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1358.500

920.618

768.956

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

10671.800

10086.407

7915.849

 

 

 

 

 

Less

TAX                                                                  (H)

2201.200

2169.176

1801.637

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

8470.600

7917.231

6114.212

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

22011.202

18699.820

16414.995

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

NA

2654.686

1991.014

 

 

Provision for Corporate Dividend Tax

NA

451.164

338.373

 

 

Dividend of earlier year

NA

0.000

0.000

 

 

Corporate Dividend Tax of earlier year

NA

0.000

0.000

 

 

Amount transferred to General Reserve

NA

1500.000

1500.000

 

BALANCE CARRIED TO THE B/S

NA

22011.202

18699.820

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

NA

22576.430

18601.633

 

 

Export of Service

NA

42.100

187.743

 

TOTAL EARNINGS

NA

22618.530

18789.376

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

4842.587

4479.898

 

 

Packing Material

NA

17.445

11.166

 

 

Lab Chemicals

NA

5.215

20.301

 

 

Components and Spare parts

NA

9.747

7.575

 

 

Capital goods

NA

194.365

162.425

 

TOTAL IMPORTS

NA

5069.359

4681.365

 

 

 

 

 

 

Earnings Per Share (Rs.) [Basic]

63.82

59.65

46.06

 

Earnings Per Share (Rs.) [Diluted]

63.82

59.65

46.06

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

NA

5.498

4.565

Cash generated from operations

NA

7714.829

6572.871

Net cash flow from used in operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT/Sales)

(%)

27.47

31.49

28.72

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

39.07

43.87

40.88

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

63.33

74.90

77.42

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.30

0.33

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.01

0.01

0.01

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.01

0.01

0.01

 

 

STOCK PRICES

 

Face Value

Rs.2.00/-

Market Value

Rs.1914.65/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

265.469

265.469

265.500

Reserves & Surplus

25267.312

30078.693

35354.100

Share Application money pending allotment

0.000

0.000

0.000

Net worth

25532.781

30344.162

35619.600

 

 

 

 

long-term borrowings

21.004

15.506

10.500

Short term borrowings

305.145

163.237

250.700

Total borrowings

326.149

178.743

261.200

Debt/Equity ratio

0.013

0.006

0.007

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

21288.899

25139.654

30840.100

 

 

18.088

22.675

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

21288.899

25139.654

30840.100

Profit

6114.212

7917.231

8470.600

 

28.72%

31.49%

27.47%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 


 

UNSECURED LOAN:

 

Particulars

31.03.2015

Rs. In Million

31.03.2014

Rs. In Million

Long Term Borrowings

 

 

Deferred Payment Liabilities

 

 

Deferred Sales Tax Credit

NA

21.004

Less: Current maturities of long-term debt

NA

(5.498)

Total

NA

15.506

 

Notes:

 

Term of Repayment:

 

Period: 14 Years

Number of Installments due: 4

Rate of Interest: Interest free

 

The above liability due thereon has been paid upto date and there are no continuing defaults.

 

 

 

 

 

CORPORATE INFORMATION

 

Divi’s Laboratories Limited (the Company or Divi’s) is a manufacturer of Active Pharmaceutical Ingredients and Intermediates having headquarters at Hyderabad, India. The major portion of its turnover is on account of export of its products to European and American countries. The Company’s main manufacturing and research and development facilities are located in the State of Andhra Pradesh, India. The Equity Shares of the Company are listed in The Bombay Stock Exchange Limited, Mumbai and The National Stock Exchange, Mumbai.

 

 

CONTINGENT LIABILITIES

 

Particulars

31.03.2015

Rs. In Million

31.03.2014

Rs. In Million

(i) On account of Letter of Credit and Guarantees issued by the bankers

NA

543.530

(ii) Demands being disputed / contested by the Company

NA

264.498

 

 

INDEX OF CHARGE:

 

SR. NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10024113

28/10/2006

209,000,000.00

THE BANK OF NOVA SCOTIA

6-3-346/1, ROAD # 1, BANJARA HILLS, HYDERABAD, ANDHRA PRADESH - 500034, INDIA

A06138333

2

90138352

17/06/2002

150,000,000.00

UTI BANK LIMITED

6-3-346/1, ROAD # 1, BANJARA HILLS, HYDERABAD, ANDHRA PRADESH - 500034, INDIA

-

3

90138306

12/07/2002 *

100,000,000.00

UTI BANK LIMITED

6-3-346/1, ROAD # 1, BANJARA HILLS, HYDERABAD, ANDHRA PRADESH - 500034, INDIA

-

4

90138250

24/05/2001 *

50,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA (IDBI)

IDBI TOWER; WTC COMPLEX, CUFFE PURADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

5

90138195

06/12/2000 *

50,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER; WTC COMPLEX, CUFFE PURADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

6

90138180

06/02/2000

50,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER; WTC COMPLEX, CUFFE PURADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

7

90138171

16/12/2000 *

40,000,000.00

IDBI BANK LIMITED

MAHAVIR HOUSE, BASHEER BAGH SQUARE, HYDERABAD, ANDHRA PRADESH - 500029, INDIA

-

8

90138083

06/10/1999 *

630,000,000.00

STATE BANK OF HYDERABAD

IFB; PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

9

90137956

08/12/1998 *

672,200,000.00

STATE BANK OF HYDERABAD

IFB; PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

10

90136781

17/10/1996 *

552,400,000.00

STATE BANK OF HYDERABAD

IFB; PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

11

90137918

19/11/2003 *

552,400,000.00

STATE BANK OF HYDERABAD

IFB; PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

12

90137910

03/10/1996 *

102,600,000.00

THE LAKSHMI VILAS BANK LIMITED

KUKATPALLY BRANCH, HYDERABAD, ANDHRA PRADESH, INDIA

-

13

90137909

01/10/1996 *

341,800,000.00

STATE BANK OF HYDERABAD

INDUSTRIAL FINANCE BRANCH, PANJAGUTTA, HYDERABAD,
ANDHRA PRADESH - 500482, INDIA

-

14

90137905

17/10/1996 *

70,000,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

15

90137843

24/03/1997 *

425,000,000.00

STATE BANK OF HYDERABAD

IFB; PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

16

90137810

20/04/2006 *

37,500,000.00

THE LAKSHMI VILAS BANK LIMITED

KUKATPALLY, HYDERABAD, ANDHRA PRADESH - 500872, INDIA

-

17

90137808

13/11/2006 *

886,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH, 5-9-300, ABIDS, HYDERABAD, ANDHRA PRADESH - 500001, INDIA

-

18

90137793

05/01/1996 *

50,000,000.00

INDUSTRIAL RECONSTRUCTION BANK OF INDIA

19; NETAJI SUBHAS ROAD, CULCUTTA, WEST BENGAL - 700001, INDIA

-

19

90137772

20/08/2001 *

220,000,000.00

STATE BANK OF HYDERABAD

IFB PANJAGUTTA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

-

20

90137762

24/11/2006 *

1,095,000,000.00

STATE BANK OF HYDERABAD

INDUSTRIAL FINANCE BRANCH, "TOPAZ" BUILDING, AMRU THA HILLS, PUNJAGUTTA, HYDERABAD, ANDHRA PRADESH- 500082, INDIA

-

21

90137748

20/04/2006 *

132,000,000.00

STATE BANK OF HYDERABAD

INDUSTRIAL FINANCE BRANCH, "TOPAZ" BUILDING, AMRU THA HILLS, PUNJAGUTTA, HYDERABAD, ANDHRA PRADESH- 500082, INDIA

-

22

90137718

14/11/1995 *

219,500,000.00

INDUSTRIAL DEVELOPMENT BANK OF INDIA

IDBI TOWER, CUFFE PURADE, MUMBAI, MAHARASHTRA - 400005, INDIA

-

23

90137702

31/03/2005 *

37,500,000.00

THE LAKSHMI VILAS BANK LIMITED

KUTAPALLY, HYDERABAD, ANDHRA PRADESH - 500872, INDIA

-

 

 

FIXED ASSETS:

 

·         Land and Development

·         Buildings

·         Plant and Machinery

·         Laboratory Equipment

·         Furniture and Fixtures

·         Data Processing Equipment

·         Vehicles

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 63.37

UK Pound

1

Rs. 98.85

Euro

1

Rs. 69.96

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

9

PAID-UP CAPITAL

1~10

9

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

74

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.